Nonalcoholic Fatty Liver Disease: The Role of Visceral Adipose Tissue
Courtney L. Hanlon, Liyun Yuan – 27 January 2022
Letter to the editor: Both universal screening and vaccination are essential components of a multipronged approach to hepatitis B elimination
Calvin Q. Pan, Ira M. Jacobson, Paul Martin, Paul Kwo, Joseph Lim, Steven‐Huy B. Han, Ke‐Qin Hu, Joseph Ahn, Myron J. Tong – 27 January 2022
Improving the fitness of the NASH clinical trial: Standardizing the standard‐of‐care intervention
Matthew R. Kappus, Yuval A. Patel, Andres Duarte‐Rojo – 27 January 2022
Letter to the editor: Selection of appropriate statistical methods for prediction model
Zhixin Huang, Dong Yang, Yan Huang, Guang Xu, Xintong Liu – 27 January 2022
Telemedicine and Health Disparities
Jennifer C. Price, Dinee C. Simpson – 27 January 2022
A Primer to the Diagnostic and Clinical Utility of Spleen Stiffness Measurement in Patients With Chronic Liver Disease
Andrea Mladenovic, Raj Vuppalanchi, Archita P. Desai – 27 January 2022
NASH and the Gut Microbiome: Implications for New Therapies
Cynthia J. Tsay, Joseph K. Lim – 27 January 2022
Epidemiology of Liver Diseases in India
Dipankar Mondal, Kausik Das, Abhijit Chowdhury – 27 January 2022
Reply
Najib Ben Khaled, Daniel Rössler, Florian P. Reiter, Julia Mayerle, Christian M. Lange, Max Seidensticker, Markus Guba, Enrico N. De Toni – 27 January 2022
Blood Pressure Variability in Liver Transplant Recipients: The Who, What, When, and How
Jeremy Louissaint, Brett E. Fortune – 27 January 2022